Bacterial infections Ceftobiprole Ceftolozane / tazobactam IND Citric acid / lactic acid / potassium bitartrate IND Clindamycin Dalbavancine IND Durlobactam / sulbactam Eravacycline Oritavancin diphosphate IND SER 109 Tebipenem COVID-19 APN01 Anakinra IND Baricitinib IND Casirivimab / imdevimab Treatment of COVID-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19. Prevention of COVID-19 in adults and adolescents aged 12 years and older weighing at least 40 kg . Extension of indication to include treatment of COVID-19 in hospitalised patients in adults and adolescents aged 12 years and older weighing at least 40 kg for Ronapreve IND Molnupiravir PF-07321332 / ritonavir Remdesivir Treatment of paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen) or other non-invasive ventilation at start of treatment IND Treatment of paediatric patients (weighing at least 40kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19 IND Tixagevimab / cilgavimab Pre-expositie profylaxe van COVID-19 bij volwassenen en adolescenten van 12 jaar en ouder met een lichaamsgewicht van tenminste 40 kilo Evusheld is indicated for the treatment of adults and adolescents (aged 12 years and older weighing at least 40kg) with COVID‑19, who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID‑19. IND Fungal infections Ibrexafungerp Oteseconazole Rezafungin HIV Doravirine / lamivudine / tenofovirdisoproxil IND Lenacapavir Raltegravir BS UB 421 Infectious diseases other Baloxavir marboxil IND Cefepime / Enmetazobactam Fluticasone propionate Parasitic infections Lotilaner Viral infections other Bizalimogene ralaplasmid Bulevirtide Letermovir Extension of Letermovir From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant IND Letermovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients IND Lonafarnib IND Maribavir Nirsevimab Posoleucel Tenofovir alafenamide IND